FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Inomagen Therapeutics Awarded $1.6 million NIH SBIR Phase 2 Grant
Proceeds from the award will be utilized to continue the advancement of the company’s novel gene therapy for the treatment of atrial fibrillation (AF), the world’s most common arrythmia.
Bluegrass Vascular Closes $5 Mil Convertible Debt Financing
Funding will support the acceleration of the commercial expansion of Bluegrass Vascular’s Surfacer® System.
Ceros Financial Services Arranges $15MM Financing for Pristine Surgical
"Pristine Surgical has brought the endoscope into the 21st Century, improving the endoscopic procedure for both patient and surgeon,” said Mark Goldwasser, CEO of Ceros Financial Services.
Saluda Medical Announces $125M Equity Financing
Net proceeds from the financing will be used to operationalize and scale commercialization of the Evoke® Spinal Cord Simulation System (SCS) for chronic pain.
Diality Closes $24 Million of Series B2 Financing
The Series B2 round of funding will be used for activities to support 510(k) clearance, preparing for the home clinical study and to build a U.S. commercial organization.
XRHealth Secures $10M in Funding
XRHealth, the gateway to the healthcare metaverse, announced today that they raised $10M in funding to expand virtual healthcare treatment in the Metaverse. The funding was backed...
Gesund.ai Exits Stealth with $2M in Funding
Gesund’s superhighway of clinical-grade AI clears the way to safer, more effective tools to help improve medical outcomes for patients.
Supira Medical Closes $30M in an Oversubscribed Series C Financing
The funds will be used to finalize product development and initiate a first-in-human clinical study for the company's high-flow, low-profile percutaneous ventricular assist device (pVAD).
Lazurite Holdings Reports University Hospitals Ventures to Expand Collaboration with Lazurite™ & Invest in the Company
Lazurite Holdings had announced its collaboration with UH Ventures on a human factors study of the ArthroFree™ system in August.
Medical Device News Magazine
